- Home
- ACTG vs PRME Comparison
ACTG vs PRME Comparison
Compare ACTG & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTG
- PRME
- Stock Information
- Founded
- ACTG 1993
- PRME 2019
- Country
- ACTG United States
- PRME United States
- Employees
- ACTG N/A
- PRME N/A
- Industry
- ACTG Multi-Sector Companies
- PRME Medicinal Chemicals and Botanical Products
- Sector
- ACTG Miscellaneous
- PRME Health Care
- Exchange
- ACTG Nasdaq
- PRME Nasdaq
- Market Cap
- ACTG 414.8M
- PRME 379.1M
- IPO Year
- ACTG 1996
- PRME 2022
- Fundamental
- Price
- ACTG $4.44
- PRME $2.91
- Analyst Decision
- ACTG Strong Buy
- PRME Strong Buy
- Analyst Count
- ACTG 1
- PRME 9
- Target Price
- ACTG $7.00
- PRME $13.13
- AVG Volume (30 Days)
- ACTG 203.4K
- PRME 1.1M
- Earning Date
- ACTG 03-13-2025
- PRME 02-28-2025
- Dividend Yield
- ACTG N/A
- PRME N/A
- EPS Growth
- ACTG N/A
- PRME N/A
- EPS
- ACTG 0.39
- PRME N/A
- Revenue
- ACTG $165,779,000.00
- PRME $800,000.00
- Revenue This Year
- ACTG N/A
- PRME N/A
- Revenue Next Year
- ACTG $84.79
- PRME $477.62
- P/E Ratio
- ACTG $11.39
- PRME N/A
- Revenue Growth
- ACTG 261.08
- PRME N/A
- 52 Week Low
- ACTG $3.78
- PRME $2.56
- 52 Week High
- ACTG $5.74
- PRME $9.77
- Technical
- Relative Strength Index (RSI)
- ACTG 54.57
- PRME 46.51
- Support Level
- ACTG $4.31
- PRME $2.63
- Resistance Level
- ACTG $4.44
- PRME $2.92
- Average True Range (ATR)
- ACTG 0.10
- PRME 0.22
- MACD
- ACTG 0.02
- PRME 0.01
- Stochastic Oscillator
- ACTG 87.50
- PRME 29.17
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. Acacia evaluates opportunities based on the attractiveness of the underlying cash flows, without regard to a specific investment horizon. Acacia operates its businesses based on three key principles of people, process, and performance and has built a management team with demonstrated expertise in research, transactions and execution, and operations and management.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.